“ipos” Archives

in
Entry Author Date Location
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle 04/23/20 National
Zentalis Leads a Trio of Biotechs Charting a Course for Wall Street 03/09/20 New York
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
After Drought, Digital Health’s Summer of IPOs Brings Validation 08/14/19 National
Livongo Upsizes IPO to $355M in Bid to Become Netflix of Health 07/24/19 San Francisco
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts 07/18/19 National
IPO to Watch: Digital Health Developer Livongo Plans to Go Public 07/01/19 San Francisco
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Auth0 Gets “Unicorn” Status as It Raises $103M for Security Tools 05/20/19 Seattle
Seattle’s Outreach Joins Unicorn Ranks With $114M Funding Round 04/16/19 Seattle
Impinj Unveils New Circuits Aimed at Expanding Firm’s IoT Platform 03/29/19 Seattle
Steering Lyft’s IPO: What Investors Will Weigh During the Roadshow 03/07/19 San Francisco
7 Tips for Biotech Companies Seeking Capital in a Volatile Market 02/28/19 National
Kaleido Bio Downsizes IPO, Raises $75M for Microbiome Drug Tests 02/27/19 Boston
From Alnylam to Zayner: Xconomy’s Top Innovation Stories of 2018 12/27/18 National
Udacity Achieves 50,000 Nanodegree Grads Amid Company Reorganization 12/13/18 San Francisco
Synthorx Gets $131M in Upsized IPO for Synthetic Biology Drugs 12/07/18 San Diego
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
Orchard, Fueled by GSK’s Ex-Gene Therapy Biz, Nets $200M in IPO 10/31/18 Boston
With $500M Toyota Deal, Uber Sheds Go-It-Alone Driverless Car Goal 08/28/18 Detroit Ann Arbor
Bio Roundup: EpiPen Shortage, Bluebird’s Bet, Biotech IPOs & More 08/24/18 National
Another $100M Boosts Valuation of Boston’s Actifio to $1.3B 08/07/18 Boston
Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups   07/27/18 National
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined 05/24/18 Boston
Seattle Tech IPO Watch: Avalara, nLight, Smartsheet & More 05/16/18 Seattle
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid 05/15/18 National
Expectations Rise on Q1 Surge in Venture Funding; and Top 10 Deals 04/10/18 National
BioCrossroads Report: Life Science Sector Thriving, With Room to Grow 04/06/18 Indiana
Page 1 of 19 next page »